“Long-term Clinical Efficacy and Safety of Thalidomide in Patients with Transfusion‑dependent β‑thalassemia Major”, IJBR, vol. 3, no. 1, pp. 784–791, Jan. 2025, doi: 10.70749/ijbr.v3i1.595.